Arcutis Biotherapeutics Inc (ARQT)
10.14
-0.10
(-0.98%)
USD |
NASDAQ |
Nov 22, 16:00
10.13
-0.01
(-0.10%)
After-Hours: 20:00
Arcutis Biotherapeutics Revenue (TTM): 138.71M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 138.71M |
| June 30, 2024 | 132.06M |
| March 31, 2024 | 106.39M |
| Date | Value |
|---|---|
| December 31, 2023 | 59.61M |
| September 30, 2023 | 49.04M |
| June 30, 2023 | 11.66M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
11.66M
Minimum
Jun 2023
138.71M
Maximum
Sep 2024
82.91M
Average
83.00M
Median
Revenue (TTM) Benchmarks
| Mirum Pharmaceuticals Inc | 307.03M |
| Biogen Inc | 9.608B |
| Vertex Pharmaceuticals Inc | 10.63B |
| NovaBay Pharmaceuticals Inc | 13.84M |
| Palatin Technologies Inc | -- |